Blue Square Asset Management’s Pfizer PFE Stock Holding History

Blue Square Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-43,306	Closed	-$1.57M	–	87
2021 Q1	$1.57M	Buy	43,306 +2,299	+6%	+$81.6K	1%	25
2020 Q4	$1.51M	Sell	41,007 -9,710	-19%	-$356K	1.01%	24
2020 Q3	$1.77M	Buy	50,717 +10,370	+26%	+$364K	1.22%	23
2020 Q2	$1.25M	Sell	40,347 -8,621	-18%	-$293K	0.86%	32
2020 Q1	$1.52M	Buy	48,968 +12,268	+33%	+$418K	1.4%	17
2019 Q4	$1.36M	Sell	36,700 -4,807	-12%	-$171K	1.06%	22
2019 Q3	$1.42M	Buy	+41,507	New	+$1.51M	1.11%	26

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Blue Square Asset Management's PFE Position: Q2 2021 in Review

Blue Square Asset Management sold out of Pfizer (PFE) in Q2 2021, closing a stake of 43,306 shares — an estimated $1.57M sold.

Blue Square Asset Management first reported a position in PFE in Q3 2019 and held it in 7 quarters. The position peaked at $1.77M in Q3 2020. 2,733 funds tracked by Wall St. Rank hold PFE as of Q2 2021.

Blue Square Asset Management reported no remaining Pfizer position as of Q2 2021 after selling out during the quarter.
Blue Square Asset Management sold 43,306 Pfizer shares in Q2 2021, an estimated $1.57M.
Blue Square Asset Management first reported a position in Pfizer in Q3 2019 and held it in 7 quarters.
Blue Square Asset Management's Pfizer position peaked at $1.77M in Q3 2020.
2,733 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.

Based on Blue Square Asset Management's 13F filing for Q2 2021, filed 4 Aug 2021.